v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Balance at beginning of period (in shares) at Dec. 30, 2023   36,551,221      
Balance at beginning of period at Dec. 30, 2023 $ 845,250 $ 366 $ 0 $ (23,915) $ 868,799
Exercise of stock options (in shares)   4,408      
Exercise of stock options 367 $ 0 367 0 0
Withholdings from vesting of restricted stock (in shares)   (90,922)      
Withholdings from vesting of restricted stock (7,378) $ (1) (5,535) 0 (1,842)
Restricted stock activity (in shares)   243,120      
Restricted stock activity 0 $ 2 (2) 0 0
Stock-based compensation expense 5,170 $ 0 5,170 0 0
Repurchase of common stock (in shares)   (107,795)      
Repurchase of common stock (8,999) $ (1) 0 0 (8,998)
Cash dividends declared and paid (29,338) 0 0 0 (29,338)
Comprehensive income $ 36,281 $ 0 0 (1,752) 38,033
Balance at end of period (in shares) at Mar. 30, 2024 36,600,032 36,600,032      
Balance at end of period at Mar. 30, 2024 $ 841,353 $ 366 0 (25,667) 866,654
Balance at beginning of period (in shares) at Dec. 28, 2024 36,041,995 36,041,995      
Balance at beginning of period at Dec. 28, 2024 $ 854,562 $ 360 3,856 (43,678) 894,024
Withholdings from vesting of restricted stock (in shares)   (93,538)      
Withholdings from vesting of restricted stock (4,222) $ (1) (4,221) 0 0
Restricted stock activity (in shares)   288,657      
Restricted stock activity 0 $ 3 (3) 0 0
Stock-based compensation expense 9,753 0 9,753 0 0
Cash dividends declared and paid (28,999) 0 0 0 (28,999)
Comprehensive income $ 16,151 $ 0 0 612 15,539
Balance at end of period (in shares) at Mar. 29, 2025 36,237,114 36,237,114      
Balance at end of period at Mar. 29, 2025 $ 847,245 $ 362 $ 9,385 $ (43,066) $ 880,564